Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Conditions:   Ebola Virus Disease;   Marburg Virus Disease Interventions:   Biological: cAd3-Marburg;   Biological: cAd3-EBO-S Sponsors:   Albert B. Sabin Vaccine Institute;   ICON plc;   Oklahoma Blood Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials